Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.

Related Content:

• Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
• Screening for Helicobacter pylori to Prevent Gastric Cancer